A New Biomarker Copeptin in Determining Disease Severity in COVID-19
In our study, copeptin was identified as a new prognostic biomarker indicating the severity of the disease in patients with COVID-19.
Authors
- Havva Koçak (ORCID: https://orcid.org/0000-0002-7147-0179)
- Pınar Korkmaz (ORCID: https://orcid.org/0000-0001-5035-5895)
- Duru Mıstanoğlu Özatağ (ORCID: https://orcid.org/0000-0002-0005-192X)
- Havva Keskin (ORCID: https://orcid.org/0000-0003-1794-4473)
- Selcen Uçar (ORCID: https://orcid.org/0000-0003-2326-5565)
Institutions
- Ankara University (TR)
- Kütahya Dumlupınar Üniversitesi (TR)
- Education Training And Research (US)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Infectious Diseases and Clinical Microbiology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.36519/idcm.2024.324
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39